Dr. Anita Lyn Sabichi is a medical oncologist specializing in translational biology and molecular medicine at the Baylor College of Medicine in Houston.
Board Certified in Medical Oncology
Pleural and Lung Cancer
20+ Years of Experience
She is involved in experimental therapeutics of lung, head and neck cancers. Sabichi helped investigate a clinical trial involving bevacizumab in the treatment of head and neck cancers. Bevacizumab, also known by brand name Avastin, was recently added to the National Comprehensive Cancer Network’s first-line mesothelioma treatment recommendations.
Sabichi, who has been in practice for more than 20 years, graduated from the University of Colorado School of Medicine. She completed her residency at New York Presbyterian Hospital and her fellowship at the National Institutes of Health Clinical Center.
Disclaimer: Dr. Anita Lyn Sabichi has no professional affiliation with Asbestos.com.
Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers. Read More